NCT01514929View on ClinicalTrials.gov

A Study to Evaluate the Effect of IV ACHN-490 Injection on the QT/QTc Interval in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

October 31, 2011

Study Completion Date

March 31, 2012

Conditions
Cardiac Effects in Normal Healthy Volunteers
Interventions
DRUG

ACHN-490 Injection

20mg/kg IV 30 minute infusion given once

DRUG

ACHN-490 Injection

15mg/kg IV 30 minute infusion given once

DRUG

Moxifloxacin

400mg oral pill given once

DRUG

Placebo

Placebo oral pill given once

Trial Locations (1)

53095

Investigational Site, West Bend

Sponsors

Lead Sponsor

Achaogen, Inc.
All Listed Sponsors
collaborator

Department of Health and Human Services

FED

lead

Achaogen, Inc.

INDUSTRY